DT&CRO CO., Ltd. Logo

DT&CRO CO., Ltd.

A full-service CRO providing non-clinical and clinical studies for various industries.

383930 | KO

Overview

Corporate Details

ISIN(s):
KR7383930005
LEI:
Country:
South Korea
Address:
경기도 용인시 처인구 백령로20번길 28 나동 2, 3, 4층(유방동), 용인시

Description

DT&CRO CO., Ltd. is a full-service Contract Research Organization (CRO) that provides a comprehensive series of commissioned studies for the biopharmaceutical, chemical, functional food, and cosmetics sectors. The company's services span the entire development lifecycle, from non-clinical research, including GLP toxicity, pharmacokinetics (PK), and efficacy tests, to clinical trials, analysis, and regulatory consulting. Specialized offerings include a full-package service for FDA IND and NDA submissions, developed in partnership with Radyus Research. DT&CRO also provides an in-house SEND (Standard for Exchange of Nonclinical Data) program to streamline FDA registration and approval. Additionally, the company offers MoPS, a proprietary IT program that enables sponsors to manage projects and communicate with specialists in real-time.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2024-09-23 00:00
전환가액의조정 (제1회차)
Korean HTML 11.5 KB
2024-08-14 00:00
반기보고서 (2024.06)
Korean HTML 951.9 KB
2024-05-14 00:00
분기보고서 (2024.03)
Korean HTML 967.2 KB
2024-05-13 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.0 KB
2024-05-02 00:00
[기재정정]신규시설투자등
Korean HTML 11.5 KB
2024-05-02 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.7 KB
2024-04-04 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 21.1 KB
2024-04-04 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 21.0 KB
2024-03-29 00:00
정기주주총회결과
Korean HTML 24.7 KB
2024-03-21 00:00
감사보고서제출
Korean HTML 18.8 KB
2024-03-21 00:00
사업보고서 (2023.12)
Korean HTML 442.2 KB
2024-03-14 00:00
주주총회소집결의
Korean HTML 13.4 KB
2024-03-14 00:00
주주총회집중일개최사유신고
Korean HTML 4.8 KB
2024-03-14 00:00
주주총회소집공고
Korean HTML 86.7 KB
2024-02-22 00:00
증권발행결과(자율공시) (제1회차)
Korean HTML 6.0 KB

Automate Your Workflow. Get a real-time feed of all DT&CRO CO., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DT&CRO CO., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DT&CRO CO., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.